< Back to previous page

Publication

Avelumab (anti-PD-L1) in patients with platinum-refractory/ineligible recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Results from a phase Ib cohort

Journal Contribution - Journal Article Conference Contribution

Journal: ANNALS OF ONCOLOGY

ISSN: 0923-7534

Volume: 31

Pages: S664 - S664

Publication year:2020

Institutional Repository URL: https://lirias.kuleuven.be/3262000
DOI: https://doi.org/10.1016/j.annonc.2020.08.1035
WoS Id: 000573469101208